肝细胞癌患者就医障碍的种族与民族差异
该研究在大型多样化新诊断肝细胞癌(HCC)患者人群中描述患者报告的就医障碍,并按种族和民族检查障碍差异;原文指出少数种族和民族群体HCC负担更重,但少有研究探讨患者报告障碍的差异,理解这些数据对制定干预措施以减少差异至关重要。
要点
- 研究在大型多样化新诊断HCC患者中描述患者报告的就医障碍。
- 按种族和民族检查就医障碍的差异。
- 原文指出少数种族和民族群体HCC负担更重,包括发病率更高、诊断更晚期和生存更差。
核心结论
- 原文旨在描述患者报告的就医障碍并按种族和民族检查差异,以帮助制定干预措施解决和减轻差异。
研究设计与样本
- 原文为在大型多样化新诊断肝细胞癌患者人群中描述患者报告就医障碍并检查种族和民族差异的研究。
主要发现
- 原文未报告具体研究结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is a leading cause of death in patients with cirrhosis and has a rising mortality rate in the United States.1 Racial and ethnic minorities experience a disproportionate burden of HCC, including higher incidence rates, more late-stage diagnoses, and worse survival.2,3 These disparities are complex in nature and can be attributed to many proximal, intermediate, and distal determinants, such as health literacy and behaviors, social support, social needs, social determinants of health, and access to health care.4 Prior studies have identified racial and ethnic differences in clinical factors, including receipt of HCC surveillance and tumor stage5; however, few studies have examined differences in patient-reported barriers that may partly explain observed disparities. Understanding these data is essential to inform interventions to address and mitigate disparities. Therefore, we described patient-reported barriers to medical care and examined differences in barriers by race and ethnicity in a large, diverse population of patients newly diagnosed with HCC.
引用
- Schoenberger H, Rich NE, Jones P, et al. Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2021. PMID: 34965448. doi:10.1016/j.cgh.2021.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。